BEAUTY, THOUGHTFULLY. FROM SEOUL.

TREATMENTS

Juvelook Volume 100 and the Rest of the Line: Read the Label Before Booking

Understand the manufacturer’s listed pack amounts, record the exact product and ask how the proposed treatment fits your follow-up plans.

Juvelook Volume 100 vials and labelled boxes in VAIM’s official September 2026 launch photograph
Image: VAIM / Juvelook — Volume 100 official product photograph

Juvelook is a product family, not one universally interchangeable vial. If a Seoul clinic menu uses only the brand name, ask which complete product name is proposed before agreeing to a treatment. Record the package, amount and follow-up plan rather than comparing a nickname alone.

VAIM’s September 10 announcement describes Volume 100 as an addition to the existing 200mg Volume product and dates its launch to September 9, 2026. The new vial contains 85mg PDLLA and 15mg hyaluronic acid. Those are contents of the product, not a recommended individual dose or a ready-to-inject liquid volume.

Read the full product name

The current Korean manufacturer page lists Juvelook i and Skin at 30mg, Juvelook at 50mg, Volume 100 at 100mg, and Volume and G at 200mg. Their listed PDLLA and HA amounts differ with the pack. Equal total amounts also do not establish that two named products are interchangeable.

The page describes a Korean Class IV medical device and gives a labelled purpose of temporary improvement of adult facial wrinkles through physical restoration after subcutaneous administration of polylactide and hyaluronic acid. A clinic’s broader menu language should not be mistaken for the manufacturer’s stated Korean intended purpose.

Keep milligrams separate from treatment volume

A number on a vial label does not tell you the final prepared volume, number of injection sites or treatment appropriate for you. Ask the clinician to explain which amount refers to the original product and which refers to the proposed procedure. Do not derive a personal treatment plan from this label guide.

The manufacturer presents Volume 100 as a single-person, single-vial option that broadens its range. That description does not establish that everyone needs a full vial or that a smaller number is preferable. Product selection, preparation and suitability belong in the clinical consultation.

Leave with a record you can use after the trip

  • Ask for the complete product name, lot number and expiry details in your treatment record.
  • Ask to see the sealed, labelled product and any manufacturer authentication material.
  • Confirm the amount used and how the clinician documents preparation.
  • Request written aftercare and a contact method that works after you leave Korea.
  • Discuss risks, alternatives and whether your travel schedule allows appropriate review.

The pictured vial and box are VAIM’s official Volume 100 product photograph. They identify an example in the range; they do not endorse a provider or predict an outcome. Before booking, ask the clinician to reconcile the exact label with the proposed plan and arrange follow-up that remains practical after departure.

EXPLORE THIS STORY

Continue reading